相关实验视频
Updated: Sep 10, 2025

15:48
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
9.7K
释放未来ALS治疗的新机制:使用胆固醇抗剂的早期干预可以减少神经肌肉衰退
Reynaldo Popoli1, Tyler L Wells1, Turgay Akay1
1Atlantic Mobility Action Project, Brain Repair Center, Dept. of Medical Neuroscience, Dalhousie University, Halifax, NS, CANADA, B3H 0A8.
Journal of neurophysiology
|August 27, 2025
概括
胆固醇抗剂如阿特罗宾和美托克拉在治疗肌缩侧面硬化症 (ALS) 中表现有前途. 这些药物改善了小鼠的运动功能和肌肉健康,为ALS患者提供了潜在的新疗法.
科学领域:
- 神经科学
- 药理学
背景情况:
- 肌缩侧面硬化 (ALS) 是一种致命的神经退行性疾病,导致运动神经元的损失和.
- 运动期间活跃的突触与延迟的ALS症状有关.
- 目前对人类的基因操纵是有限的.
研究的目的:
- 在ALS小鼠模型中研究胆抗剂的治疗潜力.
- 探索这些药物在运动和不运动中对疾病进展的影响.
- 确定这些干预措施是否能够保持运动功能和肌肉内.
主要方法:
- 在ALS小鼠模型中给药阿特罗宾和美托克拉.
- 对运动性能 (跑步机,握力) 和体重的影响评估.
- 在人性终点上评估肌肉内.
- 与运动并发或不并发的药物疗效的研究.
主要成果:
- 在ALS小鼠中,阿特罗平和美托克拉显著改善了运动功能和体重维持.
- 肌肉内置明显增强,表明对运动控制的损失有保护作用.
- 在没有运动的情况下,甲托克拉的益处更大,这表明了新的胆能机制.
- 观察到的益处与C-buton无关,而美托克拉并没有穿过血脑屏障.
结论:
- 药物学上对胆固醇传播的操纵为ALS提供了一个有前途的治疗策略.
- 这些药物可以减轻肌肉损伤并减缓疾病的进展.
- 这些发现表明一种可转换的治疗方法可以保护ALS患者的运动功能.
相关概念视频
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
825
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
825
Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.0K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.0K
Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.3K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.3K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
869
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
869
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
645
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
645

